Yttrium (90 y) citrate colloid

Yttriga Precursor Radiofarmaceutico en Solucion

0,005 - 15 µg precursor radiofarmacéuticoSpainMarketedAuthorised 21 Jun 2011

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Yttrium (90 y) citrate colloid

Yttriga Precursor Radiofarmaceutico en Solucion

0,005 - 15 µg precursor radiofarmacéuticoSpainMarketedAuthorised 21 Jun 2011

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Yttrium-90 Chloride Sterile SolutionCanada · 52 MCI / VIAL · Solution · MDS Nordion, A Division of MDS (Canada) INC.

Ittrio (90Y) Citrato Curium ItalyItaly · Sospensione iniettabile · Curium Italy S.R.L.

Yttrium(90Y) colloïdensuspensie CIS bio international 37-370 MBq/ml suspensie voor injectieNetherlands · Suspensie voor injectie · Cis Bio International

Packs

Pack	Code	Status
YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION, 1 vial de 3 ml	677720

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Yttrium (90 y) citrate colloid
Strength: 0,005 - 15 µg
Dosage form: precursor radiofarmacéutico
Route: otra vía
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 21 Jun 2011
Registration: 05322001
Marketing authorisation holder: Eckert & Ziegler Radiopharma Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario

Spain

Ytracis, Radiofarmaco Precursor en SolucionYttrium (90 y) citrate colloid · 1850 MEGABECQUERELIO · precursor radiofarmaceutico en solucionSpainWithdrawn